Cardiac PET: Real World Applications and the Role of F-18 Labeled Tracers is a three-part webinar series, each 30 minutes, intended to increase learners’ competence in solving clinical questions in the targeted patient populations and understand the unique benefits of PET imaging with F-18 labeled tracers. The added value of MBF in making patient management decisions will also be discussed.

• Demonstrate understanding the added value of PET MPI and MBF over SPECT in obese patients, patients with diabetes, and women at risk for cardiovascular disease
• Describe the significance of F-18 labelled tracers and what they offer over SPECT imaging and other PET MPI tracers in the target populations
• Analyze recent clinical data with F-18 flurpiridaz and its potential impact on imaging women, obese patients, and women with suspected CAD
• Apply knowledge from clinical case studies demonstrating the enhanced image quality of F-18 flurpiridaz and diagnostic accuracy compared with SPECT imaging

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for 1.5 AMA PRA Category 1 Credits™ (0.5 CME per webinar). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.

The following planners, presenters, peer reviewers, and staff reported no financial relationships:
Stephen Horgan, MD
Rene Packard, MD
Viviany Taqueti, MD
Matthew Harinstein, MD (Reviewer)
Linda Giering, PhD (ASNC staff)
Wendy Passerell (ASNC staff) 

The following planners, presenters, peer reviewers, staff reported financial relationships:
Mouaz Al-Mallah, MD: Research Grant – Siemens; Consultant – Phillips, Jubilant, Pfizer
Timothy Bateman, MD: Research Grants – Bracco, GEHC, Spectrum Dynamics; Consultant – GEHC, Synektik; Ownership - CVIT
Panithaya Chareonthaitawee, MD: Consultant – Clario, Ionetix; Royalty – UpToDate
Gary Heller, MD, PhD: Advisory Board – Molecular Imaging Services, GE HealthCare
Jamshid Maddahi, MD: Consultant – GE HealthCare